PERSPECTA

News from every angle

← Back to headlines

Novo Nordisk and Eli Lilly Compete for GLP-1 Pill Market Ahead of Medicare Coverage

Novo Nordisk and Eli Lilly are intensifying their rivalry in the GLP-1 pill market as they prepare to target seniors with Medicare coverage.

8 Jun, 14:30 — 8 Jun, 14:30
PostShare

Sources

Showing 1 of 1 sources
cnbcMostly Factual23d ago

Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage

Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Mindanao Farmers Warn Against Sugarcane Planting Amid Super El Niño

just now

Oriental Mindoro Capitol Restores Five-Day Workweek

just now

Western Visayas Rice Farmers Warned of Major Pests and Diseases

just now